{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T23:58:14Z","timestamp":1776124694673,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s10822-024-00552-6","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T02:12:20Z","timestamp":1710814340000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["The AI-driven Drug Design (AIDD) platform: an interactive multi-parameter optimization system integrating molecular evolution with physiologically based pharmacokinetic simulations"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6080-8103","authenticated-orcid":false,"given":"Jeremy","family":"Jones","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9509-8132","authenticated-orcid":false,"given":"Robert D.","family":"Clark","sequence":"additional","affiliation":[]},{"given":"Michael S.","family":"Lawless","sequence":"additional","affiliation":[]},{"given":"David W.","family":"Miller","sequence":"additional","affiliation":[]},{"given":"Marvin","family":"Waldman","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,3,19]]},"reference":[{"key":"552_CR1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/978-1-4612-1480-9_9","volume-title":"Rational drug design. The IMA volumes in mathematics and its applications","author":"R Bohacek","year":"1999","unstructured":"Bohacek R, Mcmartin C, Glunz P, Rich DH (1999) Growmol, a de novo computer program, and its application to thermolysin and pepsin: results of the design and synthesis of a novel inhibitor. In: Truhlar DG, Howe WJ, Hopfinger AJ, Blaney J, Dammkoehler RA (eds) Rational drug design. The IMA volumes in mathematics and its applications. Springer, New York, pp 103\u2013114. https:\/\/doi.org\/10.1007\/978-1-4612-1480-9_9"},{"issue":"3","key":"552_CR2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/prot.340190305","volume":"19","author":"MB Eisen","year":"1994","unstructured":"Eisen MB, Wiley DC, Karplus M, Hubbard RE (1994) HOOK: a program for finding novel molecular architectures that satisfy the chemical and steric requirements of a macromolecule binding site. Proteins 19(3):199\u2013221. https:\/\/doi.org\/10.1002\/prot.340190305","journal-title":"Proteins"},{"issue":"4","key":"552_CR3","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/prot.340110409","volume":"11","author":"JB Moon","year":"1991","unstructured":"Moon JB, Howe WJ (1991) Computer design of bioactive molecules: a method for receptor-based de novo ligand design. Proteins Struct Funct Bioinform 11(4):314\u2013328. https:\/\/doi.org\/10.1002\/prot.340110409","journal-title":"Proteins Struct Funct Bioinform"},{"issue":"2","key":"552_CR4","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/BF00126441","volume":"7","author":"V Gillet","year":"1993","unstructured":"Gillet V, Johnson AP, Mata P, Sike S, Williams P (1993) SPROUT: a program for structure generation. J Comput Aided Mol Des 7(2):127\u2013153. https:\/\/doi.org\/10.1007\/BF00126441","journal-title":"J Comput Aided Mol Des"},{"issue":"1","key":"552_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/BF00124387","volume":"6","author":"HJ B\u00f6hm","year":"1992","unstructured":"B\u00f6hm HJ (1992) The computer program LUDI: a new method for the de novo design of enzyme inhibitors. J Comput Aided Mol Des 6(1):61\u201378. https:\/\/doi.org\/10.1007\/BF00124387","journal-title":"J Comput Aided Mol Des"},{"issue":"7428","key":"552_CR6","doi-asserted-by":"publisher","first-page":"7428","DOI":"10.1038\/nature11691","volume":"492","author":"J Besnard","year":"2012","unstructured":"Besnard J et al (2012) Automated design of ligands to polypharmacological profiles. Nature 492(7428):7428. https:\/\/doi.org\/10.1038\/nature11691","journal-title":"Nature"},{"key":"552_CR7","series-title":"Lecture notes in computer science","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/BFb0056008","volume-title":"Flexible query answering systems","author":"MJ Mart\u00edn-Bautista","year":"1998","unstructured":"Mart\u00edn-Bautista MJ, Vila M-A (1998) Applying genetic algorithms to the feature selection problem in information retrieval. In: Andreasen T, Christiansen H, Larsen HL (eds) Flexible query answering systems. Lecture notes in computer science. Springer, Berlin, pp 272\u2013281. https:\/\/doi.org\/10.1007\/BFb0056008"},{"issue":"1","key":"552_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1747-0285.2008.00672.x","volume":"72","author":"M Hartenfeller","year":"2008","unstructured":"Hartenfeller M, Proschak E, Sch\u00fcller A, Schneider G (2008) Concept of combinatorial de novo design of drug-like molecules by particle swarm optimization. Chem Biol Drug Des 72(1):16\u201326. https:\/\/doi.org\/10.1111\/j.1747-0285.2008.00672.x","journal-title":"Chem Biol Drug Des"},{"issue":"7","key":"552_CR9","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/s0089400060498","volume":"6","author":"R Wang","year":"2000","unstructured":"Wang R, Gao Y, Lai L (2000) LigBuilder: a multi-purpose program for structure-based drug design. Mol Model Annu 6(7):498\u2013516. https:\/\/doi.org\/10.1007\/s0089400060498","journal-title":"Mol Model Annu"},{"issue":"6","key":"552_CR10","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1023\/A:1008036704754","volume":"12","author":"Y Sun","year":"1998","unstructured":"Sun Y, Ewing TJA, Skillman AG, Kuntz ID (1998) CombiDOCK: Structure-based combinatorial docking and library design. J Comput Aided Mol Des 12(6):597\u2013604. https:\/\/doi.org\/10.1023\/A:1008036704754","journal-title":"J Comput Aided Mol Des"},{"issue":"2","key":"552_CR11","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1021\/ci0503560","volume":"46","author":"U Fechner","year":"2006","unstructured":"Fechner U, Schneider G (2006) Flux (1): a virtual synthesis scheme for fragment-based de novo design. J Chem Inf Model 46(2):699\u2013707. https:\/\/doi.org\/10.1021\/ci0503560","journal-title":"J Chem Inf Model"},{"issue":"2","key":"552_CR12","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1021\/ci6005307","volume":"47","author":"U Fechner","year":"2007","unstructured":"Fechner U, Schneider G (2007) Flux (2): comparison of molecular mutation and crossover operators for ligand-based de novo design. J Chem Inf Model 47(2):656\u2013667. https:\/\/doi.org\/10.1021\/ci6005307","journal-title":"J Chem Inf Model"},{"issue":"3","key":"552_CR13","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1021\/ci034290p","volume":"44","author":"N Brown","year":"2004","unstructured":"Brown N, McKay B, Gilardoni F, Gasteiger J (2004) A graph-based genetic algorithm and its application to the multiobjective evolution of median molecules. J Chem Inf Comput Sci 44(3):1079\u20131087. https:\/\/doi.org\/10.1021\/ci034290p","journal-title":"J Chem Inf Comput Sci"},{"key":"552_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.sbi.2021.10.001","volume":"72","author":"M Wang","year":"2022","unstructured":"Wang M et al (2022) Deep learning approaches for de novo drug design: an overview. Curr Opin Struct Biol 72:135\u2013144. https:\/\/doi.org\/10.1016\/j.sbi.2021.10.001","journal-title":"Curr Opin Struct Biol"},{"issue":"3","key":"552_CR15","doi-asserted-by":"publisher","first-page":"e1581","DOI":"10.1002\/wcms.1581","volume":"12","author":"Q Bai","year":"2022","unstructured":"Bai Q et al (2022) Application advances of deep learning methods for de novo drug design and molecular dynamics simulation. WIREs Comput Mol Sci 12(3):e1581. https:\/\/doi.org\/10.1002\/wcms.1581","journal-title":"WIREs Comput Mol Sci"},{"issue":"3","key":"552_CR16","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1021\/acs.jcim.8b00839","volume":"59","author":"N Brown","year":"2019","unstructured":"Brown N, Fiscato M, Segler MHS, Vaucher AC (2019) GuacaMol: benchmarking models for de novo molecular design. J Chem Inf Model 59(3):1096\u20131108. https:\/\/doi.org\/10.1021\/acs.jcim.8b00839","journal-title":"J Chem Inf Model"},{"issue":"20","key":"552_CR17","doi-asserted-by":"publisher","first-page":"11964","DOI":"10.1021\/acs.jmedchem.0c01148","volume":"63","author":"JT Bush","year":"2020","unstructured":"Bush JT et al (2020) A turing test for molecular generators. J Med Chem 63(20):11964\u201311971. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c01148","journal-title":"J Med Chem"},{"issue":"12","key":"552_CR18","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1021\/acsinfecdis.6b00144","volume":"2","author":"MA Phillips","year":"2016","unstructured":"Phillips MA et al (2016) A triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor with improved drug-like properties for treatment and prevention of malaria. ACS Infect Dis 2(12):945\u2013957. https:\/\/doi.org\/10.1021\/acsinfecdis.6b00144","journal-title":"ACS Infect Dis"},{"issue":"12","key":"552_CR19","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1021\/jm8001026","volume":"51","author":"MA Phillips","year":"2008","unstructured":"Phillips MA et al (2008) Triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors with potent and selective activity against the malaria parasite Plasmodium falciparum. J Med Chem 51(12):3649\u20133653. https:\/\/doi.org\/10.1021\/jm8001026","journal-title":"J Med Chem"},{"issue":"7","key":"552_CR20","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1021\/jm801343r","volume":"52","author":"R Gujjar","year":"2009","unstructured":"Gujjar R et al (2009) Identification of a metabolically stable triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor with antimalarial activity in mice. J Med Chem 52(7):1864\u20131872. https:\/\/doi.org\/10.1021\/jm801343r","journal-title":"J Med Chem"},{"issue":"11","key":"552_CR21","doi-asserted-by":"publisher","first-page":"3935","DOI":"10.1021\/jm200265b","volume":"54","author":"R Gujjar","year":"2011","unstructured":"Gujjar R et al (2011) Lead optimization of aryl and aralkyl amine-based triazolopyrimidine inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with antimalarial activity in mice. J Med Chem 54(11):3935\u20133949. https:\/\/doi.org\/10.1021\/jm200265b","journal-title":"J Med Chem"},{"issue":"39","key":"552_CR22","doi-asserted-by":"publisher","first-page":"26999","DOI":"10.1074\/jbc.M109.028589","volume":"284","author":"X Deng","year":"2009","unstructured":"Deng X et al (2009) Structural plasticity of malaria dihydroorotate dehydrogenase allows selective binding of diverse chemical scaffolds. J Biol Chem 284(39):26999\u201327009. https:\/\/doi.org\/10.1074\/jbc.M109.028589","journal-title":"J Biol Chem"},{"issue":"12","key":"552_CR23","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1021\/jm500481t","volume":"57","author":"X Deng","year":"2014","unstructured":"Deng X et al (2014) Fluorine modulates species selectivity in the triazolopyrimidine class of Plasmodium falciparum dihydroorotate dehydrogenase inhibitors. J Med Chem 57(12):5381\u20135394. https:\/\/doi.org\/10.1021\/jm500481t","journal-title":"J Med Chem"},{"issue":"15","key":"552_CR24","doi-asserted-by":"publisher","first-page":"5540","DOI":"10.1021\/jm200592f","volume":"54","author":"JM Coteron","year":"2011","unstructured":"Coteron JM et al (2011) Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potent Plasmodium falciparum dihydroorotate dehydrogenase inhibitors with clinical candidate potential. J Med Chem 54(15):5540\u20135561. https:\/\/doi.org\/10.1021\/jm200592f","journal-title":"J Med Chem"},{"issue":"17","key":"552_CR25","doi-asserted-by":"publisher","first-page":"7425","DOI":"10.1021\/jm300351w","volume":"55","author":"A Marwaha","year":"2012","unstructured":"Marwaha A et al (2012) Bioisosteric transformations and permutations in the triazolopyrimidine scaffold to identify the minimum pharmacophore required for inhibitory activity against Plasmodium falciparum dihydroorotate dehydrogenase. J Med Chem 55(17):7425\u20137436. https:\/\/doi.org\/10.1021\/jm300351w","journal-title":"J Med Chem"},{"issue":"11","key":"552_CR26","doi-asserted-by":"publisher","first-page":"5416","DOI":"10.1021\/acs.jmedchem.6b00275","volume":"59","author":"S Kokkonda","year":"2016","unstructured":"Kokkonda S et al (2016) Tetrahydro-2-naphthyl and 2-Indanyl triazolopyrimidines targeting Plasmodium falciparum dihydroorotate dehydrogenase display potent and selective antimalarial activity. J Med Chem 59(11):5416\u20135431. https:\/\/doi.org\/10.1021\/acs.jmedchem.6b00275","journal-title":"J Med Chem"},{"issue":"2","key":"552_CR27","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1021\/ed080p214","volume":"80","author":"BT Burlingham","year":"2003","unstructured":"Burlingham BT, Widlanski TS (2003) An intuitive look at the relationship of Ki and IC50: a more general use for the dixon plot. J Chem Educ 80(2):214. https:\/\/doi.org\/10.1021\/ed080p214","journal-title":"J Chem Educ"},{"issue":"11","key":"552_CR28","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s10822-020-00333-x","volume":"34","author":"RD Clark","year":"2020","unstructured":"Clark RD et al (2020) Design and tests of prospective property predictions for novel antimalarial 2-aminopropylaminoquinolones. J Comput Aided Mol Des 34(11):1117\u20131132. https:\/\/doi.org\/10.1007\/s10822-020-00333-x","journal-title":"J Comput Aided Mol Des"},{"key":"552_CR29","doi-asserted-by":"publisher","unstructured":"Singh A, Minsker B, Goldberg DE (2012) Combining reliability and pareto optimality\u2014an approach using stochastic multi-objective genetic algorithms. pp 1\u201310. https:\/\/doi.org\/10.1061\/40685(2003)93","DOI":"10.1061\/40685(2003)93"},{"issue":"1","key":"552_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1162\/evco.1995.3.1.1","volume":"3","author":"CM Fonseca","year":"1995","unstructured":"Fonseca CM, Fleming PJ (1995) An overview of evolutionary algorithms in multiobjective optimization. Evol Comput 3(1):1\u201316. https:\/\/doi.org\/10.1162\/evco.1995.3.1.1","journal-title":"Evol Comput"},{"issue":"11","key":"552_CR31","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s10822-008-9227-2","volume":"23","author":"RD Clark","year":"2009","unstructured":"Clark RD, Abrahamian E (2009) Using a staged multi-objective optimization approach to find selective pharmacophore models. J Comput Aided Mol Des 23(11):765\u2013771. https:\/\/doi.org\/10.1007\/s10822-008-9227-2","journal-title":"J Comput Aided Mol Des"},{"issue":"12","key":"552_CR32","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s10822-004-6986-2","volume":"18","author":"N Brown","year":"2004","unstructured":"Brown N, McKay B, Gasteiger J (2004) The de novo design of median molecules within a property range of interest. J Comput Aided Mol Des 18(12):761\u2013771. https:\/\/doi.org\/10.1007\/s10822-004-6986-2","journal-title":"J Comput Aided Mol Des"},{"issue":"2","key":"552_CR33","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1021\/ci010375j","volume":"42","author":"VJ Gillet","year":"2002","unstructured":"Gillet VJ, Khatib W, Willett P, Fleming PJ, Green DVS (2002) Combinatorial library design using a multiobjective genetic algorithm. J Chem Inf Comput Sci 42(2):375\u2013385. https:\/\/doi.org\/10.1021\/ci010375j","journal-title":"J Chem Inf Comput Sci"},{"issue":"1","key":"552_CR34","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13321-021-00561-9","volume":"13","author":"X Liu","year":"2021","unstructured":"Liu X, Ye K, van Vlijmen HWT, Emmerich MTM, IJzerman AP, van Westen GJP (2021) DrugEx v2: de novo design of drug molecules by Pareto-based multi-objective reinforcement learning in polypharmacology. J. Cheminform 13(1):85. https:\/\/doi.org\/10.1186\/s13321-021-00561-9","journal-title":"J. Cheminform"},{"key":"552_CR35","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/978-3-642-01020-0_36","volume-title":"Evolutionary multi-criterion optimization. Lecture notes in computer science","author":"JW Kruisselbrink","year":"2009","unstructured":"Kruisselbrink JW, Emmerich MTM, B\u00e4ck T, Bender A, Ijzerman AP (2009) Combining aggregation with pareto optimization: a case study in evolutionary molecular design. In: Ehrgott M, Fonseca CM, Gandibleux X, Hao J-K, Sevaux M (eds) Evolutionary multi-criterion optimization. Lecture notes in computer science. Springer, Berlin, pp 453\u2013467"},{"key":"552_CR36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/164_2015_23","volume":"232","author":"MS Lawless","year":"2016","unstructured":"Lawless MS, Waldman M, Fraczkiewicz R, Clark RD (2016) Using cheminformatics in drug discovery. Handb Exp Pharmacol 232:139\u2013168. https:\/\/doi.org\/10.1007\/164_2015_23","journal-title":"Handb Exp Pharmacol"},{"key":"552_CR37","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/978-1-4939-9089-4_8","volume":"1939","author":"RD Clark","year":"2019","unstructured":"Clark RD, Daga PR (2019) Building a quantitative structure-property relationship (QSPR) model. Methods Mol Biol (Clifton NJ) 1939:139\u2013159. https:\/\/doi.org\/10.1007\/978-1-4939-9089-4_8","journal-title":"Methods Mol Biol (Clifton NJ)"},{"key":"552_CR38","doi-asserted-by":"publisher","first-page":"107621","DOI":"10.1016\/j.pharmthera.2020.107621","volume":"215","author":"D AmaralSilva","year":"2020","unstructured":"AmaralSilva D, Pate DW, Clark RD, Davies NM, El-Kadi AOS, L\u00f6benberg R (2020) Phytocannabinoid drug\u2013drug interactions and their clinical implications. Pharmacol Ther 215:107621. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107621","journal-title":"Pharmacol Ther"},{"issue":"9","key":"552_CR39","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1002\/ps.4935","volume":"74","author":"RD Clark","year":"2018","unstructured":"Clark RD (2018) Predicting mammalian metabolism and toxicity of pesticides in silico. Pest Manag Sci 74(9):1992\u20132003. https:\/\/doi.org\/10.1002\/ps.4935","journal-title":"Pest Manag Sci"},{"issue":"1","key":"552_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"23","author":"CA Lipinski","year":"1997","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23(1):3\u201325. https:\/\/doi.org\/10.1016\/S0169-409X(96)00423-1","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"552_CR41","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S0019-9958(65)90241-X","volume":"8","author":"LA Zadeh","year":"1965","unstructured":"Zadeh LA (1965) Fuzzy sets. Inf Control 8(3):338\u2013353. https:\/\/doi.org\/10.1016\/S0019-9958(65)90241-X","journal-title":"Inf Control"},{"issue":"7","key":"552_CR42","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1021\/acs.molpharmaceut.2c00040","volume":"19","author":"D Naga","year":"2022","unstructured":"Naga D, Parrott N, Ecker GF, Olivares-Morales A (2022) Evaluation of the success of high-throughput physiologically based pharmacokinetic (HT-PBPK) modeling predictions to inform early drug discovery. Mol Pharm 19(7):2203\u20132216. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.2c00040","journal-title":"Mol Pharm"},{"issue":"1","key":"552_CR43","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1758-2946-1-8","volume":"1","author":"P Ertl","year":"2009","unstructured":"Ertl P, Schuffenhauer A (2009) Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions. J Cheminform 1(1):8. https:\/\/doi.org\/10.1186\/1758-2946-1-8","journal-title":"J Cheminform"},{"issue":"3","key":"552_CR44","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/cmdc.200700139","volume":"3","author":"R Brenk","year":"2008","unstructured":"Brenk R et al (2008) Lessons learnt from assembling screening libraries for drug discovery for neglected diseases. ChemMedChem 3(3):435\u2013444. https:\/\/doi.org\/10.1002\/cmdc.200700139","journal-title":"ChemMedChem"},{"issue":"9","key":"552_CR45","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1359-6446(97)01083-0","volume":"2","author":"GM Rishton","year":"1997","unstructured":"Rishton GM (1997) Reactive compounds and in vitro false positives in HTS. Drug Discov Today 2(9):382\u2013384. https:\/\/doi.org\/10.1016\/S1359-6446(97)01083-0","journal-title":"Drug Discov Today"},{"key":"552_CR46","unstructured":"Daylight Theory: SMARTS\u2014a language for describing molecular patterns. https:\/\/www.daylight.com\/dayhtml\/doc\/theory\/theory.smarts.html Accessed 9 June 2023"},{"issue":"2","key":"552_CR47","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nchem.1243","volume":"4","author":"GR Bickerton","year":"2012","unstructured":"Bickerton GR, Paolini GV, Besnard J, Muresan S, Hopkins AL (2012) Quantifying the chemical beauty of drugs. Nat Chem 4(2):90\u201398. https:\/\/doi.org\/10.1038\/nchem.1243","journal-title":"Nat Chem"},{"key":"552_CR48","unstructured":"Daylight Theory: SMIRKS - A Reaction Transform Language. https:\/\/www.daylight.com\/dayhtml\/doc\/theory\/theory.smirks.html Accessed 9 June 2023"},{"key":"552_CR49","doi-asserted-by":"publisher","unstructured":"Selecting a voting method: the case for the Borda count | SpringerLink. https:\/\/doi.org\/10.1007\/s10602-022-09380-y Accessed 9 June 2023","DOI":"10.1007\/s10602-022-09380-y"},{"key":"552_CR50","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ddtec.2020.09.003","volume":"32\u201333","author":"P Renz","year":"2019","unstructured":"Renz P, Van Rompaey D, Wegner JK, Hochreiter S, Klambauer G (2019) On failure modes in molecule generation and optimization. Drug Discov Today Technol 32\u201333:55\u201363. https:\/\/doi.org\/10.1016\/j.ddtec.2020.09.003","journal-title":"Drug Discov Today Technol"},{"issue":"2","key":"552_CR51","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1021\/acscentsci.7b00572","volume":"4","author":"R G\u00f3mez-Bombarelli","year":"2018","unstructured":"G\u00f3mez-Bombarelli R et al (2018) Automatic chemical design using a data-driven continuous representation of molecules. ACS Cent Sci 4(2):268\u2013276","journal-title":"ACS Cent Sci"},{"issue":"4","key":"552_CR52","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1021\/acs.jcim.1c01545","volume":"62","author":"S-G Kang","year":"2022","unstructured":"Kang S-G, Morrone JA, Weber JK, Cornell WD (2022) Analysis of training and seed bias in small molecules generated with a conditional graph-based variational autoencoder\u2500insights for practical AI-driven molecule generation. J Chem Inf Model 62(4):801\u2013816. https:\/\/doi.org\/10.1021\/acs.jcim.1c01545","journal-title":"J Chem Inf Model"},{"issue":"16","key":"552_CR53","doi-asserted-by":"publisher","first-page":"8736","DOI":"10.1021\/jacs.2c13467","volume":"145","author":"DM Anstine","year":"2023","unstructured":"Anstine DM, Isayev O (2023) Generative models as an emerging paradigm in the chemical sciences. J Am Chem Soc 145(16):8736\u20138750. https:\/\/doi.org\/10.1021\/jacs.2c13467","journal-title":"J Am Chem Soc"},{"issue":"1","key":"552_CR54","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13321-023-00781-1","volume":"15","author":"K Handa","year":"2023","unstructured":"Handa K, Thomas MC, Kageyama M, Iijima T, Bender A (2023) On the difficulty of validating molecular generative models realistically: a case study on public and proprietary data. J Cheminform 15(1):112. https:\/\/doi.org\/10.1186\/s13321-023-00781-1","journal-title":"J Cheminform"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-024-00552-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-024-00552-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-024-00552-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T07:15:39Z","timestamp":1732605339000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-024-00552-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,19]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["552"],"URL":"https:\/\/doi.org\/10.1007\/s10822-024-00552-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3270269\/v1","asserted-by":"object"}]},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,19]]},"assertion":[{"value":"16 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MSL, DSM and JJ are currently employed by Simulations Plus, Inc., and own stock in the company or options on the stock thereof. RDC and MW are former employees but still hold stock in the company. The authors declare no competing interests beyond those implicit in their employment by their respective institutions. All authors are current or former employees of Simulations Plus, Inc., which distributes the software described in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"14"}}